Rituximab maintenance after bendamustine-based treatment for follicular lymphoma and mantle cell lymphoma may exert a negative influence on SARS-CoV-2 infection outcomes.

Haematologica

Servei d'Hematologia, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona.

Published: July 2024

Not available.

Download full-text PDF	Source
http://dx.doi.org/10.3324/haematol.2024.285219	DOI Listing

Publication Analysis

Top Keywords

rituximab maintenance

maintenance bendamustine-based

bendamustine-based treatment

treatment follicular

follicular lymphoma

lymphoma mantle

mantle cell

cell lymphoma

lymphoma exert

exert negative

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!